$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
What types of epilepsy patients is Vigabatrin (vigabatrin) suitable for?
2026-02-01 22:25:32
Check Details
Mobotinib (mobosetinib) medication experience and case sharing for lung cancer patients
2026-02-01 22:25:32
Check Details
Differences between domestically produced and imported upadatinib: price, efficacy and quality comparison
2026-02-01 22:25:32
Check Details
Nintedanib treatment instructions for idiopathic pulmonary fibrosis
2026-02-01 22:25:32
Check Details
Will the price of bimetinib/bemetinib change significantly after it is included in medical insurance?
2026-02-01 22:25:32
Check Details
Brief introduction to the instruction manual of Teclistamab-cqyv
2026-02-01 22:25:32
Check Details
Where to buy Quizartinib at a lower price
2026-02-01 22:25:32
Check Details
What are the common side effects of pomalidomide and how to deal with them?
2026-02-01 22:25:32
Check Details
How much does a box of lapatinib cost and how cost-effective it is?
2026-02-01 22:25:32
Check Details
Does filgotinib belong to the class of selective JAK inhibitors?
2026-02-01 22:25:32
Check Details
What are the alternatives to trientine for the treatment of drug-resistant hepatolenticular degeneration?
2026-02-01 22:25:32
Check Details
Bosutinib/bosutinib or imatinib, which one is more effective in treating chronic myelopathy?
2026-02-01 22:25:32
Check Details
1
2
...
1639
1640
1641
1642
1643
1644
1645
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
2
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
3
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
4
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
5
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
6
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
7
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
8
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
9
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
10
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
11
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
12
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment